Exelixis

Entity > Corporation > US > New York City New York > Exelixis

About Exelixis

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Exelixis

Company Attribute Value
Name Exelixis
Url exelixis
Google google
Wikidata wikidata

Exelixis

us

New York City, US
18 Feb 2024

New York City, US
18 Feb 2024

Exelixis

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.linkedin.com/company/exelixis
Exelixis
https://en.wikipedia.org › wiki › Exelixis
Exelixis
https://finance.yahoo.com › quote › EXEL
Exelixis, Inc. (EXEL) Stock Price, News, Quote & History
https://www.fiercebiotech.com › biotech › exelixis-lay...
Exelixis lays off 175 employees in refocus on 'emerging ...
https://twitter.com/ExelixisInc?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Exelixis (@ExelixisInc) · X
https://www.globaldata.com › All Companies
Exelixis Inc Company Profile
https://ipira.berkeley.edu › exelixis-inc
Exelixis, Inc.
Related Searches
Related Searches
exelixis meaning
exelixis layoffs
exelixis cabozantinib
Knowledge Panel
Knowledge Panel

Exelixis (Biotechnology company)

exelixis.com/

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

en.wikipedia.org/wiki/Exelixis
  • Stock price : EXEL (NASDAQ) $20.48 -0.11 (-0.53%)Feb 16, 4:00 PM EST - Disclaimer
  • Headquarters : Alameda, CA
  • CEO : Michael M. Morrissey (Jul 2010–)
  • Subsidiaries : Exelixis Patent Company LLC, Exelixis U.S., LLC, MORE
  • Revenue : 1.435 billion USD (2021)
  • Number of employees : 954 (2021)
  • Founded : November 15, 1994, Cambridge, MA
  • President : Michael M. Morrissey

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 89677